Fenofibrate was discovered by Laboratoires Fournier of France. What is interesting to note is Abbott also sells a version of fenofibrate after obtaining an FDA approval to market it under the brand name TriCor. Fenofibrate being one of the widely used anti-cholesterol drug to treat patients who are at risk of cardio-vascular diseases and with the license agreement coming into effect, one would be curious to know how both, Lupin and Abbott would benefit from the license. However, much cannot be said since the terms of the agreement are confidential.
Please find the patent details on Fenofibrate as follows: